2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of theGenomic Biomarker Market?

The rise in chronic health conditions is anticipated to fuel the expansion of the genomic biomarker market in the future. Chronic medical conditions are diseases that endure over longer periods and typically progress at a slow pace. The incidence of such diseases is on the rise, largely due to an aging global population and escalating rates of conditions tied to lifestyle behaviors, including obesity and diabetes. Genomic biomarkers offer a means to identify and prevent chronic diseases early by understanding genetic predispositions and personalizing interventions. This forward-thinking approach can decrease the incidence of diseases by focusing on individuals who are at risk before they develop the disease. In relation to this, as of September 2023, the World Health Organization (WHO), an intergovernmental body from Switzerland, confirmed that each year, 41 million chronic disease-related deaths occur globally, making up 74% of all deaths. The breakdown includes 17.9 million deaths due to cardiovascular diseases, 9.3 million because of cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the growing incidence of chronic diseases necessitates the expansion of the genomic biomarker market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20557&type=smp

#What Long-Term Growth Rate is Expected for theGenomic Biomarker Market Between 2025 and 2034?

The size of the genomic biomarker market has seen a quick uptick in recent years. Its growth is projected to escalate from $8.4 billion in 2024 to $9.9 billion in 2025, at a compound annual growth rate (CAGR) of 18.0%. Factors such as the soaring awareness of genetic maladies, rising demand for targeted treatments, intensified utilization of big data in genomic studies, expansion of global genomic databases, and a surge in biomarker-centric clinical trials have contributed to the historic growth of the sector.

In the coming years, the genomic biomarker market is predicted to experience fast expansion, reaching $18.93 billion by 2029 with a compound annual growth rate (CAGR) of 17.6%. The anticipated growth within this forecast duration can be linked to the increasing attention on the provision of personalized drugs, escalating incidents of heart-related diseases, growing patient count suffering from neurological ailments, expanded funding in genomic studies, and rising uptake of personalized nutrition. Significant trends within this projected timeline involve technological innovation, digital healthcare, AI, machine learning, and individualized medicine.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20557

Which Cutting-Edge Market Trends Are Expected to Drive theGenomic Biomarker Market’s Growth?

Prominent businesses participating in the genomic biomarker industry are prioritizing the creation of superior products like innovative liquid biopsy assays, which facilitate comprehensive genomic profiling of solid tumors. A liquid biopsy assay refers to a diagnostic procedure that scrutinizes genetic material, typically circulating tumor DNA (ctDNA), via a blood sample to diagnose and track cancer. Recognizing genomic biomarkers can yield information about specific gene mutations, gene expression patterns, or other genetic changes related to cancer. For example, in November 2023, Illumina Inc., an American biotechnology corporation, introduced an innovative liquid biopsy assay, the TruSight Oncology 500 ctDNA v2 (TSO 500 ctDNA v2), designed for comprehensive genomic profiling of solid tumors. This assay heightens analytical sensitivity by identifying low-frequency variations with only 20 ng of cell-free DNA, a reduction from 30 ng. It provides results in less than four days, significantly speeding up genomic profiling compared to conventional techniques. The efficient workflow and impending automation are anticipated to simplify lab incorporation and enhance productivity.

What Are the Leading Market Players Impacting theGenomic Biomarker Market’s Growth Trend?

Major companies operating in the genomic biomarker market are Pfizer Inc., Roche Diagnostics, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Foundation Medicine Inc., QIAGEN N.V., Almac Group Ltd., Myriad Genetics Inc., Invitae Inc., Guardant Health Inc., Novogene Inc., Twist Bioscience Corp., NanoString Technologies Inc., Quanterix Corp., Personalis Inc., GENEWIZ Inc., Agena Bioscience Inc., Creative Diagnostics Ltd., OncoDNA SA, Genome Life Sciences Ltd., Epigenomics AG.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/genomic-biomarker-global-market-report

How Are the Key Segments of the Genomic Biomarker Market Driving Opportunities and Innovations?

The genomic biomarker market covered in this report is segmented –

1) By Type: Predictive Biomarkers, Prognostic Biomarkers

2) By Disease Indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications

3) By Validation: Analytical Validation, Clinical Validation, Clinical Utility

4) By End-User: Hospitals, Diagnostic Centers, Research Laboratories, Other End Users

Subsegments:

1) By Predictive Biomarkers: Genetic Biomarkers For Disease Susceptibility, Pharmacogenomic Biomarkers For Drug Response, Early Detection Biomarkers For Disease Prediction, Biomarkers For Treatment Response Prediction

2) By Prognostic Biomarkers: Biomarkers For Disease Progression, Biomarkers For Outcome Prediction, Survival And Recurrence Biomarkers, Biomarkers For Treatment Efficacy And Prognosis

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=20557&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theGenomic Biomarker Market?# Market Expansion?

North America was the largest region in the genomic biomarker market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomic biomarker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Genomic Biomarker Market 2025, By The Business Research Company:

Renal Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Renal Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

Cancer Biomarker Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: